跳至主要内容
临床试验/TCTR20180614004
TCTR20180614004进行中(未招募)未知

A randomized, placebo controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis

ONE0 个研究点目标入组 34 人开始时间: 2018年6月14日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
ONE
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. 20-65 year old volunteers
  • 2. Polysomnography test with apnea-hypopnea index at least 15 events per hour
  • 3. Total nasal symptom score questionnaire required more than 6
  • 4. Skin test required
  • 5. Modified Mallampati grade 1-2

排除标准

  • 1. Without serious co-morbidity disease; resistant hypertension, poor controlled cardiovascular disease, cerebrovascular disease
  • 2. Morbid obesity; body mass index was more than 30 kg/m2
  • 3. Oral appliance or continue positive airway pressure previous used
  • 4. Bi-level positive airway pressure used
  • 5. Previous intranasal steroid used within 3 months of research period
  • 6. Could not attend 2 appointments and poor technique of drug used
  • 7. Could not discontinue anti-allergy drug within 7 days of before enrollment

研究者

发起方
ONE

相似试验